24
Jan
8th Annual OPT Congress – Oligonucleotide & Precision Therapeutics
From the 13th to the 14th of March 2023 our CEO Dr. Thomas Frischmuth will take part in the 8th Annual OPT Congress – Oligonucleotide
MORE →You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information